Patents by Inventor Robert Lyle Hood

Robert Lyle Hood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11813432
    Abstract: A method for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system, the method comprising: providing an implantable drug delivery system comprising: a housing having a reservoir for containing a drug, and a port for dispensing the drug to a patient; and an emergency deactivation unit disposed between the reservoir and the port, the emergency deactivation unit comprising a composite structure comprising a biocompatible ferromagnetic mesh open to fluid flow and a hydrophobic meltable material, the hydrophobic meltable material comprising at least one hole therein for enabling a fluid to pass through the hydrophobic meltable material; implanting the implantable drug delivery system within a patient; enabling the drug to flow from the reservoir, through the at least one hole in the hydrophobic meltable material and out the port; and when drug flow is to be terminated, applying a magnetic field to the composite structure, such that a current is induced in the ferromagnetic mes
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: November 14, 2023
    Assignee: The Methodist Hospital
    Inventors: Marco Farina, Robert Lyle Hood, Alessandro Grattoni
  • Publication number: 20230201454
    Abstract: The present disclosure relates to an improved implantable drug delivery device, method, and system that is powered by compression and expansion of an inert gas contained within a compressible bellows and surrounded by a biocompatible housing that forms a reservoir which is connected to restricted channel for flow rate control and further connected to a flexible reinforced catheter that delivers medicants from the reservoir to the intrathecal space or other desired bodily tissue.
    Type: Application
    Filed: May 29, 2021
    Publication date: June 29, 2023
    Inventors: RALPH JOHNSTON, PAUL FENTON, DOUG FRANTZ, DANIEL PORTILLO, SAKETH RAM, ROBERT LYLE HOOD
  • Publication number: 20230106780
    Abstract: A positive displacement pump can include a pump mechanism having a shaft configured to rotate about its long axis; a screw rod having a continuous thread around the circumference of the screw rod, the thread configured with an upward and downward thread component wherein the screw rod is operatively coupled to the shaft and reticulates along the long axis when the shaft is rotated about the long axis; a stylus positioned to engage the thread of the screw rod; cylindrical body forming a cavity configured to house at least a portion of the screw rod and allow movement of the screw rod along the long axis of the cylindrical body providing a pumping action in the cylindrical body cavity; an inlet and an outlet provided in the cylindrical body walls fluidly coupling the cylindrical body cavity with one or more external fluid paths.
    Type: Application
    Filed: October 1, 2022
    Publication date: April 6, 2023
    Inventors: Daniel Portillo, Robert Lyle Hood
  • Publication number: 20220040406
    Abstract: A method for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system, the method comprising: providing an implantable drug delivery system comprising: a housing having a reservoir for containing a drug, and a port for dispensing the drug to a patient; and an emergency deactivation unit disposed between the reservoir and the port, the emergency deactivation unit comprising a composite structure comprising a biocompatible ferromagnetic mesh open to fluid flow and a hydrophobic meltable material, the hydrophobic meltable material comprising at least one hole therein for enabling a fluid to pass through the hydrophobic meltable material; implanting the implantable drug delivery system within a patient; enabling the drug to flow from the reservoir, through the at least one hole in the hydrophobic meltable material and out the port; and when drug flow is to be terminated, applying a magnetic field to the composite structure, such that a current is induced in the ferromagnetic mes
    Type: Application
    Filed: March 23, 2021
    Publication date: February 10, 2022
    Inventors: Marco Farina, Robert Lyle Hood, Alessandro Grattoni
  • Patent number: 10953154
    Abstract: A method for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system, the method comprising: providing an implantable drug delivery system comprising: a housing having a reservoir for containing a drug, and a port for dispensing the drug to a patient; and an emergency deactivation unit disposed between the reservoir and the port, the emergency deactivation unit comprising a composite structure comprising a biocompatible ferromagnetic mesh open to fluid flow and a hydrophobic meltable material, the hydrophobic meltable material comprising at least one hole therein for enabling a fluid to pass through the hydrophobic meltable material; implanting the implantable drug delivery system within a patient; enabling the drug to flow from the reservoir, through the at least one hole in the hydrophobic meltable material and out the port; and when drug flow is to be terminated, applying a magnetic field to the composite structure, such that a current is induced in the ferromagnetic mes
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: March 23, 2021
    Assignee: The Methodist Hospital
    Inventors: Marco Farina, Robert Lyle Hood, Alessandro Grattoni
  • Publication number: 20190133105
    Abstract: Certain embodiments are directed to device that use a Spectrum Modulated Frequency controlled LED source that strongly attracts a selected target insect or insect population to a trapping and/or killing system to facilitate the capture or disposal of selected genus of flying insects while limiting the attraction of other flying insects.
    Type: Application
    Filed: November 7, 2018
    Publication date: May 9, 2019
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Richard Raymond Leach, Roy Matthew Ringrose, Gold Darr Hood, Robert Lyle Hood
  • Publication number: 20180280617
    Abstract: A method for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system, the method comprising: providing an implantable drug delivery system comprising: a housing having a reservoir for containing a drug, and a port for dispensing the drug to a patient; and an emergency deactivation unit disposed between the reservoir and the port, the emergency deactivation unit comprising a composite structure comprising a biocompatible ferromagnetic mesh open to fluid flow and a hydrophobic meltable material, the hydrophobic meltable material comprising at least one hole therein for enabling a fluid to pass through the hydrophobic meltable material; implanting the implantable drug delivery system within a patient; enabling the drug to flow from the reservoir, through the at least one hole in the hydrophobic meltable material and out the port; and when drug flow is to be terminated, applying a magnetic field to the composite structure, such that a current is induced in the ferromagnetic mes
    Type: Application
    Filed: October 19, 2016
    Publication date: October 4, 2018
    Inventors: Marco Farina, Robert Lyle Hood, Alessandro Grattoni